Kinney Drugs acquires four independent pharmacies
GOUVERNEUR, N.Y. — Regional player Kinney Drugs has snapped up four independent pharmacies located in central New York and Vermont, bringing its total store count to 94.
Financial terms of the deal were not disclosed.
“These acquisitions are a very good fit for Kinney Drugs and are consistent with our stated growth objectives in retail pharmacy,” stated Jim Spencer, COO of Kinney Drugs store division. “They will allow us to grow our prescription base and market share within existing markets, and at the same time expand into two new areas in Central New York and Vermont.”
Two of the acquired pharmacies have been converted and remerchandised, and will operate under the Kinney Drugs name. The other two pharmacies were closed, and prescription files and inventory were transferred to the neighboring Kinney Drugs.
No comments found
Study: Fear of needles could hamper flu vaccinations
MINNEAPOLIS — Nobody likes getting a shot, but a new survey indicates that fear of needles also may prompt people to avoid getting flu vaccinations.
Target announced results of a new online survey conducted on its behalf by Harris Interactive showing that 60% of American adults would skip flu vaccinations, with 23% of those avoiding vaccinations because they don’t like needles. The survey polled 2,160 adults between July 10 and July 12; no margin of error could be calculated as the survey was not based on a probability sample.
The mass-merchandise retailer said it would offer a new intradermal flu shot option at Target Pharmacy locations for the flu season, using a micro-needle that is 90% smaller than traditional flu shot needles. The Food and Drug Administration announced Monday the approval of the vaccine formulation for the 2012-2013 flu season, and the Centers for Disease Control and Prevention recommends annual vaccinations against flu for most children and adults.
Buzzy is the only medical device that is shown to not only decrease pain, but also has proven fear relief. Buzzy4shots.com
FDA approves formulation for 2012-2013 flu vaccines
SILVER SPRING, Md. — The Food and Drug Administration has approved the formulation for the 2012-2013 flu vaccine, the agency said Monday.
The agency’s approval is for all six licensed flu vaccines for the 2012-2013 season: Afluria, made by CSL; Fluarix, made by GlaxoSmithKline; FluLaval, made by ID Biomedical; FluMist, made by MedImmune Vaccines; Fluvirin, made by Novartis; and Fluzone, made by Sanofi.
The strains selected for inclusion in the 2012-2013 vaccines are A/California/7/2009, an H1N1 strain; A/Victoria/361/2011, an H3N2 strain; and B/Wisconsin/1/2010-like virus. The FDA said that while the H1N1 virus is the same as those included in the 2011-2012 vaccines, the H3N2 and B viruses are different from last season.
The Centers for Disease Control and Prevention recommends annual flu vaccinations for most adults and children, and most major pharmacy retailers have pharmacists who can administer them.
No comments found